{"product_id":"pocket-guide-to-clinical-microbiology-paperback-softback-9781683674221","title":"Pocket Guide to Clinical Microbiology (Paperback \/ softback) 9781683674221","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003ePocket Guide to Clinical Microbiology\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cfont size=\"4\"\u003eChristopher D. Doern (Author), Alexandra L. Bryson (Author)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9781683674221, Wiley\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003ePaperback \/ softback, published 1 April 2026\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e416 pages\u003cbr\u003e21.3 x 14 x 2.3 cm, 0.408 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003cp\u003e\u003cb\u003eUser-friendly, quick clinical microbiology reference\u003c\/b\u003e \u003c\/p\u003e\n\u003cp\u003eStay ahead in clinical practice with the latest edition of \u003ci\u003ePocket Guide to Clinical Microbiology\u003c\/i\u003e. This essential companion for clinical microbiology professionals delivers concise, up-to-date information on microbial identification, diagnostics, and treatment options, tailored for quick reference at the bench and in the clinic. Featuring the latest advancements, quick-reference tables, and practical insights, it is the go-to guide for clinical microbiologists, health care professionals, and students seeking a reliable and accessible resource to enhance their knowledge and practice.\u003c\/p\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e\u003cp\u003ePreface xi\u003c\/p\u003e \u003cp\u003eAbout the Authors xv\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 1 Taxonomic Classification of Medically Important Microorganisms 1 \u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eGeneral Comments 2\u003c\/p\u003e \u003cp\u003eTaxonomic Classification of Bacteria 2\u003c\/p\u003e \u003cp\u003eTable 1.1 Reclassification of the Former Family Enterobacteriaceae 10\u003c\/p\u003e \u003cp\u003eTable 1.2 Newly Assigned Genera for Former Mycobacterium 11\u003c\/p\u003e \u003cp\u003eTable 1.3 Enterobacter cloacae Complex Organisms 12\u003c\/p\u003e \u003cp\u003eTable 1.4 Klebsiella oxytoca Complex Organisms 12\u003c\/p\u003e \u003cp\u003eTable 1.5 Taxonomy of Citrobacter freundii Complex 12\u003c\/p\u003e \u003cp\u003eTable 1.6 Taxonomy of Pseudomonas fluorescens Group Organisms 12\u003c\/p\u003e \u003cp\u003eTable 1.7 Taxonomy of Pseudomonas putida Group Organisms 13\u003c\/p\u003e \u003cp\u003eTable 1.8 Taxonomy of Pseudomonas aeruginosa Group Organisms 13\u003c\/p\u003e \u003cp\u003eTable 1.9 Taxonomy of Acinetobacter calcoaceticus-baumannii Complex 13\u003c\/p\u003e \u003cp\u003eTable 1.10 Taxonomy of Burkholderia cepacia Complex 13\u003c\/p\u003e \u003cp\u003eTable 1.11 Taxonomy of Mycobacteria 14\u003c\/p\u003e \u003cp\u003eTable 1.12 Taxonomy of the Staphylococcus aureus Complex 16\u003c\/p\u003e \u003cp\u003eTable 1.13 Taxonomy of the Staphylococcus intermedius Group 16\u003c\/p\u003e \u003cp\u003eTable 1.14 Taxonomy of the Viridans Group Streptococci 16\u003c\/p\u003e \u003cp\u003eTaxonomic Classification of Human Viruses 17\u003c\/p\u003e \u003cp\u003eTaxonomic Classification of Fungi 21\u003c\/p\u003e \u003cp\u003eTable 1.15 Revised Species Names of Selected Clinically Relevant Fungi 22\u003c\/p\u003e \u003cp\u003eTaxonomic Classification of Parasites 25\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 2 Indigenous and Pathogenic Microbes of Humans 31\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eGeneral Comments 32\u003c\/p\u003e \u003cp\u003eTable 2.1 Human Indigenous Flora 32\u003c\/p\u003e \u003cp\u003eTable 2.2 Summary of Notifiable Infectious Diseases: United States, 2016 and 2020 43\u003c\/p\u003e \u003cp\u003eTable 2.3 Arthropod Vectors of Medically Important Diseases 48\u003c\/p\u003e \u003cp\u003eTable 2.4 Fungal Pathogens and Geographic Distribution 51\u003c\/p\u003e \u003cp\u003eTable 2.5 Parasitic Pathogens and Geographic Distribution 62\u003c\/p\u003e \u003cp\u003eMicrobes Responsible for Human Disease 70\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 3 Specimen Collection and Transport 93\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eGeneral Comments 94\u003c\/p\u003e \u003cp\u003eTable 3.1 Bacteriology: Collection and Transport Guidelines 96\u003c\/p\u003e \u003cp\u003eTable 3.2 Specimen Collection and Transport Guidelines for Infrequently Encountered Bacteria 114\u003c\/p\u003e \u003cp\u003eTable 3.3 Guidelines for Collection of Specimens for Anaerobic Culture 115\u003c\/p\u003e \u003cp\u003eTable 3.4 Possible Rejection Criteria for Specimens Submitted for Bacterial Culture 116\u003c\/p\u003e \u003cp\u003eVirology: General Specimen Guidelines 117\u003c\/p\u003e \u003cp\u003eVirology: Specific Specimen Guidelines 118\u003c\/p\u003e \u003cp\u003eTable 3.5 Recommended Blood Volumes to Collect for Blood Cultures 121\u003c\/p\u003e \u003cp\u003eTable 3.6 Mycology: Collection and Transport Guidelines 122\u003c\/p\u003e \u003cp\u003eTable 3.7 Parasitology: Specimen Guidelines 127\u003c\/p\u003e \u003cp\u003eTable 3.8 Guidelines for Processing Stool Specimens for Parasites 132\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 4 Bacterial Diagnosis 135\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eGeneral Comments 136\u003c\/p\u003e \u003cp\u003eTable 4.1 Detection Methods from Clinical Specimens for Clinically Relevant Bacteria 136\u003c\/p\u003e \u003cp\u003eTable 4.2 Recommendations for Gram Stain from Primary Specimen and Plating Media 139\u003c\/p\u003e \u003cp\u003eTable 4.3 Screening Specimens for Routine Bacterial Culture 143\u003c\/p\u003e \u003cp\u003eTable 4.4 Processing Specimens for Mycobacterial Identification 144\u003c\/p\u003e \u003cp\u003eMicroscopy 144\u003c\/p\u003e \u003cp\u003ePrimary Plating Media: Bacteria 146\u003c\/p\u003e \u003cp\u003ePrimary Plating Media: Mycobacteria 159\u003c\/p\u003e \u003cp\u003eSpecific Diagnostic Tests for Pathogen Detection 161\u003c\/p\u003e \u003cp\u003eAerobic Gram-Positive Cocci 161\u003c\/p\u003e \u003cp\u003eAerobic Gram-Positive Rods 162\u003c\/p\u003e \u003cp\u003eAcid-Fast and Partially Acid-Fast Gram-Positive Rods 164\u003c\/p\u003e \u003cp\u003eAerobic Gram-Negative Cocci 164\u003c\/p\u003e \u003cp\u003eAerobic Gram-Negative Rods 165\u003c\/p\u003e \u003cp\u003eAnaerobic Bacteria 172\u003c\/p\u003e \u003cp\u003eCurved and Spiral-Shaped Bacteria 173\u003c\/p\u003e \u003cp\u003eMycoplasma spp. and Obligate Intracellular Bacteria 176\u003c\/p\u003e \u003cp\u003eIdentification Tables 178\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 5 Viral Diagnosis 217\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eGeneral Comments 218\u003c\/p\u003e \u003cp\u003eTable 5.1 Detection Methods for Viruses 218\u003c\/p\u003e \u003cp\u003eTable 5.2 Cells Used for Viral Isolation 220\u003c\/p\u003e \u003cp\u003eRNA Viruses 221\u003c\/p\u003e \u003cp\u003eDNA Viruses 229\u003c\/p\u003e \u003cp\u003eTable 5.3 EBV Serologic Profiles Under Different Conditions 231\u003c\/p\u003e \u003cp\u003eTable 5.4 Clinical Diseases of Parvovirus B19 and Method of Diagnosis 232\u003c\/p\u003e \u003cp\u003eTable 5.5 Hepatitis B Virus Markers in Different Stages of Infection and Convalescence 233\u003c\/p\u003e \u003cp\u003eTransmissible Spongiform Encephalopathies 235\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 6 Fungal Diagnosis 237\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eMycology: Specimen Collection and Transport Guidelines 238\u003c\/p\u003e \u003cp\u003eTable 6.1 Methods for the Identification of Fungi 240\u003c\/p\u003e \u003cp\u003eMicroscopy 240\u003c\/p\u003e \u003cp\u003eTable 6.2 Characteristic Fungal Elements Seen by Direct Examination of Clinical Specimens 243\u003c\/p\u003e \u003cp\u003ePrimary Plating Media 246\u003c\/p\u003e \u003cp\u003eTable 6.3 Mycology Plating Guide 249\u003c\/p\u003e \u003cp\u003eSpecific Diagnostic Tests 251\u003c\/p\u003e \u003cp\u003eAspergillus Species 251\u003c\/p\u003e \u003cp\u003eBlastomyces dermatitidis 251\u003c\/p\u003e \u003cp\u003eCandida Species 252\u003c\/p\u003e \u003cp\u003eCoccidioides Species (Coccidioidomycosis) 252\u003c\/p\u003e \u003cp\u003eCryptococcus neoformans and gattii (Cryptococcosis) 253\u003c\/p\u003e \u003cp\u003eHistoplasma Species 253\u003c\/p\u003e \u003cp\u003eMalassezia Species 254\u003c\/p\u003e \u003cp\u003eParacoccidioides brasiliensis 254\u003c\/p\u003e \u003cp\u003eTalaromyces (Penicillium) marneffei 255\u003c\/p\u003e \u003cp\u003ePneumocystis jirovecii 255\u003c\/p\u003e \u003cp\u003eSporothrix schenckii 255\u003c\/p\u003e \u003cp\u003eMucormycetes (Zygomycetes) 255\u003c\/p\u003e \u003cp\u003eIdentification Tables 257\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 7 Parasitic Diagnosis 271\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eGeneral Comments 272\u003c\/p\u003e \u003cp\u003eMicroscopy 272\u003c\/p\u003e \u003cp\u003eTable 7.1 Detection Methods for Parasites 273\u003c\/p\u003e \u003cp\u003eSpecific Diagnostic Tests 277\u003c\/p\u003e \u003cp\u003eFree-Living Amebae 277\u003c\/p\u003e \u003cp\u003eIntestinal and Urogenital Protozoa 277\u003c\/p\u003e \u003cp\u003eBlood and Tissue Protozoa 280\u003c\/p\u003e \u003cp\u003eMicrosporidia 282\u003c\/p\u003e \u003cp\u003eHelminths: Nematodes 283\u003c\/p\u003e \u003cp\u003eHelminths: Trematodes 285\u003c\/p\u003e \u003cp\u003eHelminths: Cestodes 286\u003c\/p\u003e \u003cp\u003eIdentification Tables and Figures 287\u003c\/p\u003e \u003cp\u003eTable 7.2 Trophozoites of Common Intestinal Amebae 287\u003c\/p\u003e \u003cp\u003eTable 7.3 Cysts of Common Intestinal Amebae 290\u003c\/p\u003e \u003cp\u003eFigure 7.1 Intestinal Amebae of Humans 293\u003c\/p\u003e \u003cp\u003eTable 7.4 Trophozoites of Flagellates 294\u003c\/p\u003e \u003cp\u003eTable 7.5 Cysts of Flagellates 296\u003c\/p\u003e \u003cp\u003eFigure 7.2 Intestinal and Urogenital Flagellates of Humans 297\u003c\/p\u003e \u003cp\u003eTable 7.6 Morphological Characteristics of Ciliates, Coccidia, Microsporidia, and Tissue Protozoa 298\u003c\/p\u003e \u003cp\u003eTable 7.7 Morphological Characteristics of Protozoa Found in Blood 300\u003c\/p\u003e \u003cp\u003eTable 7.8 Morphological Characteristics of Blood and Tissue Nematodes 302\u003c\/p\u003e \u003cp\u003eTable 7.9 Morphological Characteristics of Helminths 303\u003c\/p\u003e \u003cp\u003eFigure 7.3 Relative Sizes of Helminth Eggs 305\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSection 8 Susceptibility Testing and Methods of Organism Identification 307\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eGeneral Comments 308\u003c\/p\u003e \u003cp\u003eSusceptibility Testing Methods 308\u003c\/p\u003e \u003cp\u003eTable 8.1 Clinical and Laboratory Standards Institute (CLSI) Documents Related to Antimicrobial Susceptibility Testing from Humans 308\u003c\/p\u003e \u003cp\u003eTable 8.2 Summary of CLSI Antimicrobial Susceptibility Test Methods for Select Bacteria, Mycobacteria, and Fungi 311\u003c\/p\u003e \u003cp\u003eAntimicrobial Treatment Information 315\u003c\/p\u003e \u003cp\u003eTable 8.3 Organisms Included in CLSI and EUCAST Breakpoint Tables 315\u003c\/p\u003e \u003cp\u003eTable 8.4 Guide to Interpretive Criteria for Select Organisms for Commonly Tested Antimicrobials 317\u003c\/p\u003e \u003cp\u003eTable 8.5 Surrogate Antibiotic Susceptibility Prediction 330\u003c\/p\u003e \u003cp\u003eTable 8.6 Routes of Administration and Drug Class for Select Antimicrobial Agents 334\u003c\/p\u003e \u003cp\u003eTable 8.7 Routes of Administration and Drug Class for Select Antifungal Agents 337\u003c\/p\u003e \u003cp\u003eTable 8.8 Routes of Administration and Drug Class for Select Antiparasitic Agents 338\u003c\/p\u003e \u003cp\u003eTable 8.9 Antibacterial Agents for Specific Bacteria 339\u003c\/p\u003e \u003cp\u003eAntimicrobial Resistance Mechanisms 345\u003c\/p\u003e \u003cp\u003eTable 8.10 Intrinsic Resistance of Selected Gram-Negative Bacteria 345\u003c\/p\u003e \u003cp\u003eTable 8.11 Intrinsic Resistance of Selected Gram-Positive Bacteria 346\u003c\/p\u003e \u003cp\u003eTable 8.12 Important Mechanisms of Multidrug Resistance in Bacteria 346\u003c\/p\u003e \u003cp\u003eTable 8.13 Activity Profiles of Select Beta-Lactam Antibiotics Against Commonly Encountered Gram-Negative Beta-Lactamases 350\u003c\/p\u003e \u003cp\u003eMALDI-TOF MS and Sequencing 351\u003c\/p\u003e \u003cp\u003eTable 8.14 Summary of MALDI-TOF MS Identification of Bacteria, Mycobacteria, and Fungi 351\u003c\/p\u003e \u003cp\u003eTable 8.15 Gene Sequencing Targets for Organism Identification 356\u003c\/p\u003e \u003cp\u003eIndex 359\u003c\/p\u003e\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Clinical \u0026amp; internal medicine [\u003ca title=\"See our other books on Clinical \u0026amp; internal medicine\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Clinical%20\u0026amp;%20internal%20medicine%20%5BMJ%5D%22\"\u003eMJ\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"ASM Press","offers":[{"title":"Brand New","offer_id":52460679201048,"sku":"9781683674221","price":39.68,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/files\/9781683674221.jpg?v=1785457948","url":"https:\/\/freshlyprintedbooks.co.uk\/products\/pocket-guide-to-clinical-microbiology-paperback-softback-9781683674221","provider":"Freshly Printed Books","version":"1.0","type":"link"}